| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-12 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-09 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |